Literature DB >> 9048207

Finally! The Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgG.

R P Junghans1.   

Abstract

F. W. Rogers Brambell was the father of the field of transmission of immunity, which he entered 50 years before the present era. As part of his quantitative and temporal studies on transmission, he defined the first Fc receptor system for IgG, and furthermore recognized the link between transmission of passive immunity from mother to young and protection from catabolism for IgG. This article provides a historical overview of the efforts of Professor Brambell and summarizes the subsequent elaboration of the details of the physiology and molecular biology of this remarkable receptor system.

Mesh：

Substances：

Year:  1997        PMID： 9048207     DOI： 10.1007/BF02786322

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   2.829


  98 in total

1.  Preferential interaction of albumin-binding proteins, gp30 and gp18, with conformationally modified albumins. Presence in many cells and tissues with a possible role in catabolism.

Authors:  J E Schnitzer; A Sung; R Horvat; J Bravo
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

2.  The relative transmission of natural and pepsin-refined homologous antitoxin from the uterine cavity to the foetal circulation in the rabbit.

Authors:  F W BRAMBELL; W A HEMMINGS; C L OAKLEY
Journal:  Proc R Soc Lond B Biol Sci       Date:  1959-04-21

3.  Separation and isolation of fractions of rabbit gamma-globulin containing the antibody and antigenic combining sites.

Authors:  R R PORTER
Journal:  Nature       Date:  1958-09-06       Impact factor: 49.962

4.  THE METABOLISM OF NORMAL PLASMA PROTEINS AND GAMMA-MYELOMA PROTEIN IN MICE BEARING PLASMA-CELL TUMORS.

Authors:  J H Humphrey; J L Fahey
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

5.  An Fc receptor structurally related to MHC class I antigens.

Authors:  N E Simister; K E Mostov
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

6.  Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding.

Authors:  R P Junghans; T A Waldmann
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

7.  Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor.

Authors:  W P Burmeister; L N Gastinel; N E Simister; M L Blum; P J Bjorkman
Journal:  Nature       Date:  1994-11-24       Impact factor: 49.962

8.  Mouse MHC class I-like Fc receptor encoded outside the MHC.

Authors:  J J Ahouse; C L Hagerman; P Mittal; D J Gilbert; N G Copeland; N A Jenkins; N E Simister
Journal:  J Immunol       Date:  1993-12-01       Impact factor: 5.422

9.  Serum and secretory immunoglobulin levels in preleukaemic AKR mice and three other mouse strains.

Authors:  J G Mink; R Benner
Journal:  Adv Exp Med Biol       Date:  1979       Impact factor: 2.622

10.  Identification of fibroblasts as a major site of albumin catabolism in peripheral tissues.

Authors:  J L Strobel; S G Cady; T K Borg; L Terracio; J W Baynes; S R Thorpe
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157
View more
  44 in total

Review 1.  The multiple roles of major histocompatibility complex class-I-like molecules in mucosal immune function.

Authors:  R S Blumberg; Y van de Wal; S Claypool; N Corazza; B Dickinson; E Nieuwenhuis; R Pitman; G Spiekermann; X Zhu; S Colgan; W I Lencer
Journal:  Acta Odontol Scand       Date:  2001-06       Impact factor: 2.331

Review 2.  Does (CUG)n repeat in DMPK mRNA 'paint' chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy?: A new hypothesis of long-range cis autosomal inactivation.

Authors:  R P Junghans; A Ebralidze; B Tiwari
Journal:  Neurogenetics       Date:  2001-03       Impact factor: 2.660

Review 3.  Transcytosis and catabolism of antibody.

Authors:  Victor Ghetie; E Sally Ward
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 4.  Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.

Authors:  Johnny X Huang; Sharon L Bishop-Hurley; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 5.  Population pharmacokinetics of therapeutic monoclonal antibodies.

Authors:  Nathanael L Dirks; Bernd Meibohm
Journal:  Clin Pharmacokinet       Date:  2010-10       Impact factor: 6.447

6.  Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts.

Authors:  Jing Li; Bo Zhou; Jianzhong Shentu; Li Du; Min Tan; Sheng Hou; Weizhu Qian; Bohua Li; Dapeng Zhang; Jianxin Dai; Hao Wang; Xu Zhang; Jianghua Chen; Yajun Guo
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

7.  Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.

Authors:  Vania Kenanova; Tove Olafsen; Desiree M Crow; Gobalakrishnan Sundaresan; Murugesan Subbarayan; Nora H Carter; David N Ikle; Paul J Yazaki; Arion F Chatziioannou; Sanjiv S Gambhir; Lawrence E Williams; John E Shively; David Colcher; Andrew A Raubitschek; Anna M Wu
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

8.  Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children.

Authors:  Courtney V Fletcher; Jaime G DeVille; Pearl M Samson; John H Moye; Joseph A Church; Hans M L Spiegel; Paul Palumbo; Terence Fenton; M Elizabeth Smith; Bobbie Graham; Joyce M Kraimer; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2007-03       Impact factor: 10.793

9.  JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody.

Authors:  Maximilian Larena; Natalie A Prow; Roy A Hall; Nikolai Petrovsky; Mario Lobigs
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

10.  Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor.

Authors:  Jaspreet Singh Jaggi; Jorge A Carrasquillo; Surya V Seshan; Pat Zanzonico; Erik Henke; Andrew Nagel; Jazmin Schwartz; Brad Beattie; Barry J Kappel; Debjit Chattopadhyay; Jing Xiao; George Sgouros; Steven M Larson; David A Scheinberg
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.